The 54 rating InvestorsObserver gives to Pacira Biosciences Inc (PCRX) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 94 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, PCRX’s 54 overall rating means the stock scores better than 54 percent of all stocks.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 54 means the stock is more attractive than 54 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Pacira Biosciences Inc Stock Today?
Pacira Biosciences Inc (PCRX) stock is lower by -4.94% while the S&P 500 is up 0.96% as of 1:08 PM on Thursday, Apr 15. PCRX has fallen -$3.43 from the previous closing price of $69.43 on volume of 451,962 shares. Over the past year the S&P 500 has gained 49.62% while PCRX is up 85.92%. PCRX earned $3.33 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 19.81.
Click Here to get the full Stock Score Report on Pacira Biosciences Inc (PCRX) Stock.
